@jd_woodsfit's TRT claims need context, we checked

What did @jd_woodsfit actually say?

The creator argued that testosterone combined with Anavar (oxandrolone) is "one of the dumbest cycles" you can do, for two reasons: it lacks structural integrity because there is nothing to manage estradiol, and it lacks meaningful results because Anavar is "one of the weakest steroids that you can possibly take." He also claimed that people who reported gaining 10 to 20 pounds on Anavar were probably taking counterfeit product, likely Dianabol or Winstrol. He flagged cholesterol and liver function as specific health risks, and criticized the use of aromatase inhibitors (AIs) by referencing what he called AI-induced "neurotoxicity."

The video is framed as opinion, but the creator is clearly advising an audience of people who are actively cycling. That framing does not make speculative pharmacology claims harmless.

Does the science back this up?

Partially, yes. Anavar is genuinely a mild anabolic steroid, and the counterfeit concern is well-documented. But the estradiol management argument is oversimplified, and the neurotoxicity claim about AIs is being used in a way that goes far beyond what the evidence actually shows.

Oxandrolone has low androgenic activity and does not aromatize, meaning it does not convert to estrogen. A testosterone-only or testosterone-plus-oxandrolone cycle does raise estradiol through the testosterone component, but the degree depends heavily on testosterone dose, individual aromatase activity, and body composition. Studies such as Testosterone and Estradiol, Rhoden and Morgentaler (2004, New England Journal of Medicine) have documented this variability. The idea that estradiol is automatically "through the roof" at 300 to 500 mg of testosterone weekly is an overstatement.

On counterfeit product: a 2020 analysis published in Drug Testing and Analysis (van der Merwe et al.) confirmed that a significant proportion of black-market oral anabolic steroids are mislabeled, including substitution of Dianabol for oxandrolone, which matches the creator's point. That part checks out.

What did they get wrong (or right)?

The cholesterol claim is one of the stronger points in this video. Oxandrolone is an oral 17-alpha-alkylated steroid, and its hepatic first-pass processing does impair HDL production significantly. A study by Hartgens and Kuipers (2004, Sports Medicine) noted that oral anabolic steroids produce more adverse lipid changes than injectable forms, primarily through hepatic effects on HDL cholesterol. The creator is right that this is a real concern.

Where he goes wrong is the neurotoxicity claim about AIs. He implies that using an AI to control estradiol is dangerous because of neurotoxicity. The evidence here is being stretched thin. Research on estrogen and neurological function, including work by Hogervorst and colleagues (2009, Cochrane Database), is primarily concerned with prolonged, complete estrogen suppression in postmenopausal women, not short-term AI use in otherwise healthy men. Weaponizing that data to suggest AIs are generally neurotoxic in male cycling contexts is misleading. It is also worth noting that crashing estradiol through aggressive AI use is a legitimate concern, but that is a dosing problem, not a categorical reason to avoid AIs entirely.

The "gives you a good pump" dismissal of oxandrolone's effects is also reductive. Oxandrolone does promote lean mass retention and strength, as shown in clinical settings (Grunfeld et al., 2006, Journal of Clinical Endocrinology and Metabolism), though these were therapeutic doses. Gains are modest, not zero.

What should you actually know?

There are real risks being gestured at in this video, but the framing is often imprecise in ways that matter clinically. Testosterone at supraphysiological doses raises estradiol for most users, and that does carry cardiovascular and symptomatic risks. Oxandrolone genuinely does produce less dramatic mass gain than other oral anabolic steroids. The counterfeit problem in black-market anabolic steroids is real and well-documented.

But using vague references to "neurotoxicity" to steer people away from estradiol management is not responsible harm reduction. Elevated estradiol in men cycling testosterone is associated with gynecomastia and fluid retention (Rhoden and Morgentaler, 2004). Telling someone not to use an AI and also not to take this stack, without giving them any actual clinical guidance, leaves a gap that can cause harm.

Anavar is a Schedule III controlled substance in the United States. Any use outside of a legitimate prescription is illegal. If you are experiencing symptoms of low testosterone or hormonal imbalance, speak with a licensed healthcare provider, not a TikTok cycling guide.